Beesiga, Brian
Marson, Kara
Fatch, Robin
Emenyonu, Nneka I.
Adong, Julian
Kekibiina, Allen
Puryear, Sarah
Lodi, Sara
McDonell, Michael G.
Muyindike, Winnie R.
Kamya, Moses R.
Hahn, Judith A.
Chamie, Gabriel http://orcid.org/0000-0002-5860-8081
Funding for this research was provided by:
National Institute on Alcohol Abuse and Alcoholism (U01AA026223, U01AA026221, K24 AA022586)
Article History
Accepted: 14 March 2023
First Online: 31 March 2023
Declarations
:
: The authors declare no conflicts of interest.
: This study was approved by the Institutional Review Boards of the University of California San Francisco, Makerere University School of Medicine Research and Ethics Committee, Mbarara University of Science and Technology Research Ethics Committee, and the Uganda National Council for Science and Technology.
: Dr. Judith Hahn served as a consultant for Pear Therapeutics in 2022.
: All participants provided written informed consent, in either English or Runyankole, to participate in the survey and the parent (DIPT trial) study.
: Not Applicable.